B G Solheim
Affiliation: Rikshospitalet University Hospital
- Clinical implications of red blood cell and platelet storage lesions: an overviewB G Solheim
Institute of Immunology, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
Transfus Apher Sci 31:185-9. 2004..This overview highlights some laboratory and clinical aspects of red cell and platelet storage lesions...
- Update on pathogen reduction technology for therapeutic plasma: an overviewB G Solheim
Institute of Immunology, Rikshospitalet Radiumhospitalet Medical Centre, University Hospital, University of Oslo, Oslo, Norway
Transfus Apher Sci 35:83-90. 2006..These questions can only be answered by a head to head comparison, followed by large-scale clinical trials...
- Rational use of blood productsB G Solheim
Institute of Immunology, Rikshospitalet, The National Hospital University of Oslo, NO 0027 Oslo, Norway
Eur J Cancer 37:2421-5; discussion 2425-7. 2001..In this Update, we discuss current blood products, then suggest transfusion "triggers" in major surgery and haematological and oncologic practice. Finally, future developments and new possibilities are considered...
- Universal fresh-frozen plasma (Uniplas): an exploratory study in adult patients undergoing elective liver resectionB G Solheim
Institute of Immunology, Rikshospitalet University Hospital, University of Oslo, Oslo, Norway
Vox Sang 89:19-26. 2005....
- Improved preservation of coagulation factors after pre-storage leukocyte depletion of whole bloodB G Solheim
Institute of Immunology, Medical Department, Rikshospitalet University Hospital, NO 0027 Oslo, Norway
Transfus Apher Sci 29:133-9. 2003..Pre-storage leukocyte depletion thus improves the coagulation factor content of plasma in stored whole blood...
- Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of bloodB G Solheim
Red Cross and National Hospital Blood Centre, Oslo, Norway
Vox Sang 74:168-75. 1998..This study was to see whether the use of 0.5 CPD resulted in better preservation of FVIII and maintenance of 2,3-BPG...
- Survival of renal allografts from living donors and the importance of being the mother of the organ donorO Flesland
Institute of Immunology, Rikshospitalet University Hospital, NO-0027 Oslo, Norway; Blood Bank, Asker and Baerum Hospital, Norway
Transfus Apher Sci 32:13-5. 2005
- Donation of stem cells from blood or bone marrow: results of a randomised study of safety and complaintsD Heldal
Medical Department, Rikshospitalet University Hospital, 0027 Oslo, Norway
Bone Marrow Transplant 29:479-86. 2002..The short-term risks of BSC mobilisation and harvest seem negligible. The potential long-term effects of G-CSF are unresolved and the donors must be followed closely...
- Viral safety of solvent/detergent-treated plasmaB G Solheim
Institute of Immunology, Rikshospitalet, The National Hospital, University of Oslo, Norway
Transfusion 40:84-90. 2000..This method, however, does not affect non-lipid-enveloped viruses. The current study investigated the viral safety of SD-treated plasma (Octaplas) and paid particular attention to the transmission of non-lipid-enveloped viruses...
- The Norwegian Plasma Fractionation Project--a 12 year clinical and economic success storyO Flesland
Blood Bank, Baerum Hospital, N 1306 Barum, Norway
Transfus Apher Sci 28:93-100. 2003....
- Prevention and diagnosis of delayed haemolytic transfusion reactionsC P Engelfriet
Sanguin Research and Sanquin Diagnostic Services, Amsterdam, The Netherlands
Vox Sang 91:353-68. 2006
- Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapyC A Akkok
Department of Immunology and Transfusion Medicine, Ullevaal University Hospital, Kirkeveien 166, N 0407 Oslo, Norway
Vox Sang 93:42-8. 2007..5 days after monitoring each PC for bacterial contamination. In this prospective observational study, we compared apheresis PCs harvested by Amicus cell separator with buffy-coat (BC) PCs during storage for up to 6.5 days...